Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.49
-1.50 (-5.17%)
At close: Nov 20, 2024, 4:00 PM
27.74
+0.25 (0.91%)
After-hours: Nov 20, 2024, 7:09 PM EST
Apellis Pharmaceuticals Employees
As of December 31, 2023, Apellis Pharmaceuticals had 706 total employees, including 702 full-time and 4 part-time employees. The number of employees decreased by 61 or -7.95% compared to the previous year.
Employees
706
Change (1Y)
-61
Growth (1Y)
-7.95%
Revenue / Employee
$1,013,054
Profits / Employee
-$354,251
Market Cap
3.42B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Acadia Healthcare Company | 23,500 |
Bausch Health Companies | 20,270 |
Envista Holdings | 12,800 |
Neogen | 2,917 |
PTC Therapeutics | 1,055 |
ImmunityBio | 628 |
Denali Therapeutics | 445 |
APLS News
- 15 days ago - Apellis Pharmaceuticals, Inc. (APLS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 25 days ago - Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G / Primary IC-MPGN - GlobeNewsWire
- 5 weeks ago - Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch - Benzinga
- 6 weeks ago - Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Apellis: Weighing Syfovre's Rapid Expansion Against Risks In The GA Market (Rating Upgrade) - Seeking Alpha
- 6 weeks ago - Kuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewsWire
- 7 weeks ago - Apellis Pharmaceuticals: Assessing The Impact Of The Negative CHMP Opinion - Seeking Alpha